7 consecutive limit up Shaanxi Meibang Pharmaceutical Group (605033.SH): experiencing severe abnormal fluctuations, drumming effect evident, potential rapid decline at any time.

Shaanxi Meibang Pharmaceutical Group (605033.SH) announced that its stock has been hitting the daily trading limit for seven consecutive trading days from January 2, 2025 to January 10, 2025. As of January 10, 2025, the company's stock has deviated by more than 100% in terms of daily closing price for the past 10 consecutive trading days, which qualifies as a serious abnormal fluctuation in stock trading according to the relevant rules of the Shanghai Stock Exchange. During the period from January 2, 2025 to January 10, 2025, the stock rose by as much as 94.85% which significantly deviates from the market and industry trends. The increase in stock price is significantly higher than that of the Shanghai Composite Index and the chemical pesticide industry during the same period. The company's latest rolling price-to-earnings ratio is 103.42, the latest price-to-book ratio is 2.80 (significantly higher than the industry average of 1.25), and the cumulative turnover rate is 50.87%. The stock price of the company has been fluctuating significantly in recent times, indicating a potential overheated market sentiment and irrational speculation. The stock is exhibiting a 'hot potato' effect, with a possibility of rapid decline at any time.